188Re-NM-01

N/A

Report date: 2025/11/14 17:54:42
NME

Base Information

Drug Name188Re-NM-01
Drug Alias Name188Re-NM-01
ClassificationRadiation-emitting products > Nuclides > Rhenium > 188ReRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates
Mechanisms of ActionProgrammed death-ligand 1 binders
TargetsProgrammed death-ligand 1
Therapy Area/IndicationsLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesNanomab Technology Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNanomab Technology LtdRadiopharm Theranostics Ltd
Inactive CompaniesN/A
Active IndicationsLung Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A